Gordon Murdo 4

What Happened

• Gordon Murdo, Executive Vice President, Global Commercial Operations at Amgen, had 6,691 shares disposed to satisfy a tax/exercise obligation. The shares were recorded at $366.21 each for a total value of $2,450,311. This was not an open-market sale but a company withholding/payment to cover taxes or exercise price (transaction code F).

Key Details

• Transaction date: 2026-03-16; Filing date: 2026-03-18 (filed two days after the transaction; appears timely).
• Shares/price: 6,691 shares at $366.21 per share; total value reported $2,450,311.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnote: The reported shares include 825 Dividend Equivalents (DEs) credited to unvested restricted stock units under Amgen’s equity plan; DEs are paid out in shares one-for-one per the vesting schedule, with cash for any fractional share (see F1).
• Transaction code: F — payment of exercise price or tax liability (shares surrendered/withheld rather than sold on the open market).

Context

• This is a tax-withholding/settlement type transaction common when equity awards vest or options are exercised; it does not necessarily indicate a change in the insider’s view of the stock. Such withholdings reduce the insider’s share count but are routine and distinct from open-market sales or purchases.